CVRTI Timeline

1967 – First Director
1967 – First Director

Maxwell M. Wintrobe, MD, then Chair of the Department of Internal Medicine, serves as the Planning Coordinator of CVRTI and later as the first Director (1969).

1969 – CVRTI Building
1969 – CVRTI Building

The Utah Board of Regents formally establishes the Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI) at the University.

1973 – Director Abildskov
1973 – Director Abildskov

JA Abildskov, MD is appointed Director and serves until 1994.

1976 Detecting Ventricular in Humans
1976 Detecting Ventricular in Humans

Drs. Abildskov, Burgess, Lux, and Vincent study he utility of body surface electrical mapping in detecting ventricular recovery properties in humans. Abildskov JA, Burgess MJ, Lux RL, Wyatt R, Vincent…
Read More

1978 An Experimental Study in Dogs
1978 An Experimental Study in Dogs

Drs. Abildskov, Burgess, and Lux demonstrate the conditions of increased local disparity of ventricular recovery which increase vulnerability to arrhythmia can be detected by analysis of the body surface electrocardiogram.…
Read More

1982 William Devries
1982 William Devries

Dr. William Devries implants the Jarvik-7 heart into Dr. Barney Clark at the University of Utah.

1984 Human Endothelial Cells
1984 Human Endothelial Cells

Drs. McIntyre, Prescott, and Zimmerman demonstrate that human endothelial cells rapidly express adhesion molecules for leukocytes when activated by prothrombotic or proinflammatory agonists. Prescott SM, Zimmerman GA, McIntyre TM. Human…
Read More

1985 Inflammatory Cell-Cell Interactions
1985 Inflammatory Cell-Cell Interactions

Drs. McIntyre, Prescott, and Zimmerman demonstrate that thrombin promotes neutrophil-endothelial interaction provided the basis for further research regarding inflammatory cell-cell interactions. Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the…
Read More

1989 First Plasma Lipid
1989 First Plasma Lipid

Drs. McIntyre, Prescott, Stafforini, and Zimmerman first demonstrate that the plasma lipid environment significantly modulates PAF hydrolase activity provided the basis for further research concerning lipid signaling and inflammatory regulation.…
Read More

1990 Relationship Between Charge Movements Associated With ICa and INa-Ca in Cardiac Myocytes
1990 Relationship Between Charge Movements Associated With ICa and INa-Ca in Cardiac Myocytes

Drs. Bridge and Spitzer show the close connection between calcium influx via calcium current and efflux via sodium-calcium exchange in heart cells. Bridge JH, Smolley JR, Spitzer KW. The relationship…
Read More

1991 Epicardial Mapping
1991 Epicardial Mapping

Taccardi and Lux publish a structural model of epicardial mapping from the body surface.

1994 Director Lux
1994 Director Lux

Robert L. Lux, PhD is appointed Director and serves until 1999.

1995 LQT
1995 LQT

Sanguinetti and Keating publish a mechanistic cause for long QT syndrome (LQT).

1997 Three-Dimensional Electrical Activation of the Ventricles
1997 Three-Dimensional Electrical Activation of the Ventricles

Drs. Ershler, Lux, and Taccardi demonstrate electrical recordings from the body surface can reliably detect three-dimensional electrical activation of the ventricles. Oster HS, Taccardi B, Lux RL, Ershler PR, Rudy…
Read More

1998 Human Platelets Translate Messenger RNAs
1998 Human Platelets Translate Messenger RNAs

Drs. Elstad, McIntyre, Prescott, Weyrich, and Zimmerman demonstrate that activated human platelets translate messenger RNAs, which are basally present in an extensive and diverse endogenous transcriptome, to critical biologically-active proteins,…
Read More

1999 Co-Directors
1999 Co-Directors

Rob MacLeod, PhD, Kenneth Spitzer, PhD, and Bruno Taccardi, MD, PhD are appointed co-Directors.

2000 ECG Imaging of Electrophysiologically Abnormal Substrates in Infarcted Hearts
2000 ECG Imaging of Electrophysiologically Abnormal Substrates in Infarcted Hearts

Drs. MacLeod and Taccardi strengthen the validity of using electrocardiographic imaging to detect and localize areas of myocardial infarct and structural disease. Burnes JE, Taccardi B, MacLeod RS, and Rudy…
Read More

2002 Dr. Tristani Identifies Several Novel Potassium Channel Mutations
2002 Dr. Tristani Identifies Several Novel Potassium Channel Mutations

Dr. Tristani identifies several novel potassium channel mutations that provide new insight concerning the mechanism of cardiac arrhythmia in patients with Anderson syndrome. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone…
Read More

2003 Director Spitzer
2003 Director Spitzer

Kenneth Spitzer, PhD is appointed Director and serves until 2019.

2003 Dr. Sheets Defines the Molecular Basis of Lidocaine’s Effect on Sodium Channel Gating
2003 Dr. Sheets Defines the Molecular Basis of Lidocaine’s Effect on Sodium Channel Gating

Dr. Sheets defines the molecular basis of lidocaine’s effect on sodium channel gating. Sheets MF and Hanck DA. Molecular action of lidocaine on the voltage sensors of sodium channels. J.…
Read More

2011 First Intracellular and Extracellular pH on Calcium Handling in Heart Cells
2011 First Intracellular and Extracellular pH on Calcium Handling in Heart Cells

The first comprehensive evaluation of selective actions of intracellular and extracellular pH on calcium handling in heart cells by Dr. Spitzer. Saegusa, N., Moorhouse, E., Vaughan-Jones, R.D., Spitzer KW. Influence…
Read More

2014 Dr. Sanguinetti Describes the Molecular Basis of Gating in a Key Potassium Channel
2014 Dr. Sanguinetti Describes the Molecular Basis of Gating in a Key Potassium Channel

Dr. Sanguinetti describes the molecular basis of gating in a key potassium channel involved in cardiac action potential repolarization. Wu W, Gardner A, Sanguinetti MC. Cooperative Subunit Interactions Mediate Fast…
Read More

2017 End-Stage Human Heart Failure Induces Development of Sheet-Like Invaginations of the Cell Membrane
2017 End-Stage Human Heart Failure Induces Development of Sheet-Like Invaginations of the Cell Membrane

Drs. Drakos, Sachse, Selzman, and Tristani-Firouzi demonstrate that end-stage human heart failure induces development of sheet-like invaginations of the cell membrane that may constitute a precondition and predictor for functional…
Read More

2017 Predicting Edema and Chronic Lesion Size
2017 Predicting Edema and Chronic Lesion Size

Drs. Dosdall, MacLeod, and Ranjan demonstrate late gadolinium enhancement-MRI done acutely after myocardial ablation can quantify edema in the tissue and correlate the acute MRI findings with chronic lesion formation.…
Read More

2018 Mitochondrial Metabolism Can Be Regulated By Smyd1
2018 Mitochondrial Metabolism Can Be Regulated By Smyd1

Drs. Franklin, Warren, and Zaitsev demonstrate mitochondrial metabolism can be regulated by Smyd1, an important modulator of gene expression in the heart. Warren J, Tracy CM, Miller MR, Makaju A,…
Read More

2019 Director Shaw
2019 Director Shaw

Robin Shaw, MD, PhD is appointed Director.

2020 The Role of Non-Glycolytic Glucose Metabolism in Myocardial Recovery
2020 The Role of Non-Glycolytic Glucose Metabolism in Myocardial Recovery

Drs. Chaudhuri, Drakos, and Selzman demonstrate heart failure patients who successfully respond to mechanical unloading have major alterations in cardiac metabolism that may facilitate their recovery. Badolia R, Ramadurai DKA,…
Read More

CVRTI Timeline